These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
627 related articles for article (PubMed ID: 15812075)
1. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer. Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A; J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075 [TBL] [Abstract][Full Text] [Related]
2. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136 [TBL] [Abstract][Full Text] [Related]
3. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I. Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale). Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G; Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419 [TBL] [Abstract][Full Text] [Related]
5. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. Yasuda H; Yamaya M; Nakayama K; Sasaki T; Ebihara S; Kanda A; Asada M; Inoue D; Suzuki T; Okazaki T; Takahashi H; Yoshida M; Kaneta T; Ishizawa K; Yamanda S; Tomita N; Yamasaki M; Kikuchi A; Kubo H; Sasaki H J Clin Oncol; 2006 Feb; 24(4):688-94. PubMed ID: 16446342 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [TBL] [Abstract][Full Text] [Related]
7. [Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients]. Cok G; Göksel T; Soyer S; Atil H; Güzelant A; Aysan T Tuberk Toraks; 2006; 54(2):161-7. PubMed ID: 16924573 [TBL] [Abstract][Full Text] [Related]
8. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766 [TBL] [Abstract][Full Text] [Related]
9. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study. Cigolari S; Curcio C; Maiorino A; Sessa R; Cioffi A; Massimo M Anticancer Res; 2003; 23(2C):1803-9. PubMed ID: 12820462 [TBL] [Abstract][Full Text] [Related]
10. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study. Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041 [TBL] [Abstract][Full Text] [Related]
11. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer. Sculier JP; Lafitte JJ; Paesmans M; Thiriaux J; Alexopoulos CG; Baumöhl J; Schmerber J; Koumakis G; Florin MC; Zacharias C; Berghmans T; Mommen P; Ninane V; Klastersky J Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424 [TBL] [Abstract][Full Text] [Related]
12. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer. Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494 [TBL] [Abstract][Full Text] [Related]
13. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. Fournel P; Robinet G; Thomas P; Souquet PJ; Léna H; Vergnenégre A; Delhoume JY; Le Treut J; Silvani JA; Dansin E; Bozonnat MC; Daurés JP; Mornex F; Pérol M; J Clin Oncol; 2005 Sep; 23(25):5910-7. PubMed ID: 16087956 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC. Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980 [TBL] [Abstract][Full Text] [Related]
15. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059 [TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study. Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N J BUON; 2007; 12(1):33-9. PubMed ID: 17436399 [TBL] [Abstract][Full Text] [Related]
17. Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience. Mir O; Alexandre J; Ropert S; Montheil V; Martin I; Durand JP; Goldwasser F Anticancer Drugs; 2009 Feb; 20(2):105-8. PubMed ID: 19209026 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998 [TBL] [Abstract][Full Text] [Related]
19. A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC). Ishikura S; Ohe Y; Nihei K; Kubota K; Kakinuma R; Ohmatsu H; Goto K; Niho S; Nishiwaki Y; Ogino T Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1117-22. PubMed ID: 15752891 [TBL] [Abstract][Full Text] [Related]
20. Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: phase II trial. Buffoni L; Dongiovanni D; Barone C; Fissore C; Ottaviani D; Dongiovanni V; Grillo R; Salvadori A; Birocco N; Schena M; Bertetto O Lung Cancer; 2006 Dec; 54(3):353-7. PubMed ID: 17049672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]